Calcium in suramin-induced rat sensory neuron toxicity in vitro

Brain Research

Volumn 742, Issue 1-2, 1996, Pages 149-156

  Xiaofeng, Sun ^a   Windebank, Anthony J ^a  

^a MAYO CLINIC   (United States)

Author keywords

calcium; calpain; dorsal root ganglia; neurite outgrowth; neurotoxicity; suramin

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALMIDAZOLIUM; NIMODIPINE; SURAMIN;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; EMBRYO; NEURITE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION;

ANIMALS; CALCIUM; CELLS, CULTURED; GANGLIA, SPINAL; NEURONS, AFFERENT; RATS; SURAMIN;

EID: 0030566697     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01003-7     Document Type: Article

References (42)

1. Blexrud, M.D. and Windebank, A.J., A tissue culture model for screening neurotoxicity of therapeutic drugs, Ann. Neurol., 30 (1991) 300 (Abstr.).
2. Bornstein M.B. Reconstituted rat-tail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. Lab. Invest. 7:1958;134-137.
3. Diochot S., Richard S., Valmier J. Diversity of voltage-gated calcium currents in large diameter embryonic mouse sensory neurons. Neuroscience. 69:1995;627-641.
4. George E.B., Glass J.D., Griffin J.W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 15:1995;6445-6452.
5. Gill J.S., Connolly D.C., McManus M.J., Maihle N.J., Windebank A.J. Suramin induces phosphorylation of the high-affinity nerve growth factor receptor in PC12 cells and dorsal root ganglion neurons. J. Neurochem. 66:1996;963-972.
6. Gill, J.S., Hoagland, V.B., Cody, H.C. and Windebank, A.J., Effect of exogenous gangliosides on dorsal root ganglion cultures exposed to suramin, J. Neurochem., 64 (1995) S10 (Abstr.).
7. Gill J.S., Hobday K.L., Windebank A.J. Mechanism of suramin toxicity in stable myelinating dorsal root ganglion cultures. Exp. Neurol. 133:1995;113-124.
8. Gill, J.S. and Windebank, A.J., Direct activation of the high affinity nerve growth factor receptor by the chemotherapeutic drug suramin, J. Neurosci., (1996) in press.
9. Goll D.E., Thompson V.F., Taylor R.G., Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays. 14:1992;549-556.
10. Kennedy M.B. Regulation of neuronal function by calcium. Trends Neurosci. 12:1989;417-420.
11. Klee C.B., Crouch T.H., Richman P.G. Calmodulin. Annu. Rev. Biochem. 49:1980;489-515.
12. Koketsu K., Cerf J.A., Nishi S. Effect of quaternary ammonium ions on electrical activity of spinal ganglion cells in frogs. J. Neurophysiol. 22:1959;177-194.
13. Koketsu K., Nishi S., Soeda H.C. Effects of calcium ions on prolonged action potentials and hyperpolarizing responses. Nature. 200:1963;786-787.
14. La Rocca R.V., Stein C.A., Danesi R., Myers C.E. Suramin, a novel antitumor compound. J. Steroid Biochem. Mol. Biol. 37:1990;893-898.
15. La Rocca R.V., Stein C.A., Myers C.E. Suramin: prototype of a new generation of antitumor compounds. Cancer Cells. 2:1990;106-115.
16. LaPorte D.C., Wierman B.M., Storm D.R. Calcium-induced exposure of a hydrophobic surface on calmodulin. Biochemistry. 19:1980;3814-3819.
17. LaRocca R.V., Meer J., Gilliatt R.W., Stein C.A., Cassidy J., Myers C.E., Dalakas M.C. Suramin-induced polyneuropathy. Neurology. 40:1990;954-960.
18. Mattson M.P., Dou P., Kater S.B. Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J. Neurosci. 8:1988;2087-2100.
19. Mattson M.P., Kater S.B. Calcium regulation of neurite elongation and growth cone motility. J. Neurosci. 7:1987;4034-4043.
20. Mattson M.P., Murrain M., Guthrie P.B., Kater S.B. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9:1989;3728-3740.
21. McCormack J.G., Halestrap A.P., Denton R.M. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 70:1990;391-425.
22. Means A.R., Dedman J.R. Calmodulin - an intracellular calcium receptor. Nature. 285:1980;73-77.
23. Miller R.J. Multiple calcium channels and neuronal function. Science. 235:1987;46-52.
24. Morgan J.I., Curran T. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 12:1989;459-462.
25. Murachi T. Intracellular regulatory system involving calpain and calpastatin. Biochem. Int. 18:1989;263-294.
26. Nixon R.A., Quackenbush R., Vitto A. Multiple calcium-activated neutral proteinases (CANP) in mouse retinal ganglion cell neurons: specificities for endogenous neuronal substrates and comparison to purified brain CANP. J. Neurosci. 6:1986;1252-1263.
27. Rogers, M.S. and Strehler, E.E., Calmodulin. In M. Celio (Ed.), Guidebook on Calcium Binding Proteins, Oxford University Press, 1996, in press.
28. Russell, J.W. and Windebank, A.J., Electrophysiological and pathological characteristics of suramin-induced neuropathy, Neurology, 43 (1993) A174 (Abstr.).
29. Russell J.W., Windebank A.J., Podratz J.L. Role of nerve growth factor in suramin neurotoxicity studied in vitro. Ann. Neurol. 36:1994;221-228.
30. Sartor O., McLellan C.A., Myers C.E., Borner M.M. Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines. J. Clin. Invest. 90:1992;2166-2174.
31. Shin C., McNamara J.O. Mechanism of epilepsy. Annu. Rev. Med. 45:1994;379-389.
32. Siesjö B.K. Calcium-mediated processes in neuronal degeneration. Ann. NY Acad. Sci. 747:1994;140-161.
33. Sueppel, K. and Windebank, A.J., The mechanism of suramin toxicity in stable myelinating dorsal root ganglion cultures, Neurology, 43 (1993) A174. (Abstr.).
34. Tanaka T., Hidaka H. Hydrophobic regions function in calmodulin-enzyme(s) interactions. J. Biol. Chem. 255:1980;11078-11080.
35. Uematsu D., Araki N., Greenberg J.H., Sladky J., Reivich M. Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage. Neurology. 41:1991;88-94.
36. Voogd T.E., Vansterkenburg E.L., Wilting J., Janssen L.H. Recent research on the biological activity of suramin. Pharmacol. Rev. 45:1993;177-203.
37. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62:1994;372-375.
38. Windebank A.J. Neurotoxicity of pyridoxine analogs is related to coenzyme structure. Neurochem. Pathol. 3:1985;159-167.
39. Windebank A.J., Blexrud M.D. Characteristics of neurite outgrowth from rat spinal ganglia: effects of serum and segmental level. J. Neuropathol. Exp. Neurol. 45:1986;683-691.
40. Windebank A.J., Blexrud M.D. Residual ethylene oxide in hollow fiber hemodialysis units is neurotoxic in vitro. Ann. Neurol. 26:1989;63-68.
41. Windebank A.J., Blexrud M.D., de Groen P.C. Potential neurotoxicity of the solvent vehicle for cyclosporine. J. Pharmacol. Exp. Ther. 268:1994;1051-1056.
42. Zimmerman U.-J.P., Schlaepfer W.W. Calcium-activated neutral protease (CANP) in brain and other tissues. Prog. Neurobiol. 23:1984;63-78.